TLL1 knockdown attenuates prostate cancer progression by enhancing antitumor immunity
Jinglan Hao, Jiaqi He, Hang Hu, Ziheng Zhu, Xi Zhao, Xiao-Yu Wu, Lan Li, Yongtong Ruan, Juan Yang, Xinyi Luo, Wei Xu, Ming Fu, Kai Zhang, Ping Hui Gao, Xiaoming Dong
This study shows that TLL1 knockdown reduces prostate cancer progression by enhancing antitumor immunity through increased CD8+ T cell infiltration.
Oncogene · Aug 4, 2025Peer-reviewedCancer Biology